Baylor University Medical Center Begins Breakthrough CAR-T Cancer Treatment for Patients with Non-Hodgkin’s … – Newswise (press release)
|
Baylor University Medical Center Begins Breakthrough CAR–T Cancer Treatment for Patients with Non-Hodgkin's …
Newswise (press release) Chimeric Antigen Receptor T cell therapy, or CAR-T, is a personalized therapy where a patient's own immune cells are removed from the patient's body, genetically reprogrammed, then infused back into the patient to identify and attack their cancer as a … |
